The cut-off value for HOMA-IR discriminating the insulin resistance based on the SHBG level in women with polycystic ovary syndrome

Introduction The study aimed to estimate the cut-off value for homeostatic model assessment for insulin resistance (HOMA-IR) discriminating the insulin resistance based on the sex hormones binding globulin (SHBG) level in women with polycystic ovary syndrome (PCOS). Materials and methods Data from medical records of 854 Caucasian women diagnosed with PCOS were analyzed. Anthropometric data, fasting plasma glucose, insulin and SHBG levels were measured. HOMA-IR was calculated with a standard formula. The cut-off value was calculated using receiver-operating characteristics. Results Circulating SHBG levels below the normal range (26.1 nmol/L) were found in 25.4% of study participants. This subgroup had a significantly higher BMI, fasting glucose and insulin concentrations and HOMA-IR values. Empirical optimal cut-off values for HOMA-IR corresponding to low SHBG levels was ≥2.1 [area under the curve (AUC) 0.73, accuracy 0.65, sensitivity 72.3%, specificity 63.1%, positive predictive value (PPV) 40.0%, negative predictive value (NPV) 87.0%]. Conclusions Our study suggests that the cut-off point for HOMA-IR discriminating the insulin resistance based on the SHBG level, in young Caucasian women with polycystic ovary syndrome is 2.1, and is consistent with the cut-off value adopted by the European Group for the Study of Insulin Resistance (above 2.0).

[1]  A. Nilsson,et al.  Longitudinal associations between sex hormone-binding globulin and insulin resistance , 2020, Endocrine connections.

[2]  D. Santi,et al.  Hormonal profile of menopausal women receiving androgen replacement therapy: a meta-analysis , 2020, Journal of Endocrinological Investigation.

[3]  J. Chudek,et al.  Estradiol/testosterone and estradiol/androstenedione indexes and nutritional status in PCOS women - A pilot study. , 2019, European journal of obstetrics, gynecology, and reproductive biology.

[4]  A. Scherzinger,et al.  Clinical prediction score of nonalcoholic fatty liver disease in adolescent girls with polycystic ovary syndrome (PCOS‐HS index) , 2019, Clinical endocrinology.

[5]  Xiaoyan Wang,et al.  Endogenous SHBG levels correlate with that of glucose transporters in insulin resistance model cells , 2019, Molecular Biology Reports.

[6]  C. Lewis,et al.  Sex Hormone–Binding Globulin Levels in Young Men Are Associated With Nonalcoholic Fatty Liver Disease in Midlife , 2019, The American journal of gastroenterology.

[7]  O. Franco,et al.  Serum testosterone, sex hormone‐binding globulin and sex‐specific risk of incident type 2 diabetes in a retrospective primary care cohort , 2018, Clinical endocrinology.

[8]  Xu Wang,et al.  Association of sex hormone-binding globulin with nonalcoholic fatty liver disease in Chinese adults , 2018, Nutrition & Metabolism.

[9]  T. Asano,et al.  Protective Effect of Sex Hormone-Binding Globulin against Metabolic Syndrome: In Vitro Evidence Showing Anti-Inflammatory and Lipolytic Effects on Adipocytes and Macrophages , 2018, Mediators of inflammation.

[10]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[11]  Yongjae Lee,et al.  Inverse Relationship between Hepatic Steatosis and Alanine Aminotransferase with Sex Hormone-Binding Globulin in Men , 2017, Yonsei medical journal.

[12]  Z. Mo,et al.  Low Serum Sex Hormone-Binding Globulin Associated with Insulin Resistance in Men with Nonalcoholic Fatty Liver Disease , 2017, Hormone and Metabolic Research.

[13]  S. Upala,et al.  Testosterone, Sex Hormone-Binding Globulin and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. , 2017, Annals of hepatology.

[14]  O. Franco,et al.  Associations of Steroid Sex Hormones and Sex Hormone–Binding Globulin With the Risk of Type 2 Diabetes in Women: A Population-Based Cohort Study and Meta-analysis , 2016, Diabetes.

[15]  Yingli Lu,et al.  Low Sex Hormone-Binding Globulin Levels Associate with Prediabetes in Chinese Men Independent of Total Testosterone , 2016, PloS one.

[16]  Qifu Li,et al.  Combined effects of sex hormone‐binding globulin and sex hormones on risk of incident type 2 diabetes , 2016, Journal of diabetes.

[17]  J. Qiao,et al.  Prevalence and predictors of metabolic abnormalities in Chinese women with PCOS: a cross- sectional study , 2014, BMC Endocrine Disorders.

[18]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[19]  S. Davis,et al.  The contribution of SHBG to the variation in HOMA‐IR is not dependent on endogenous oestrogen or androgen levels in postmenopausal women , 2012, Clinical endocrinology.

[20]  M. Rattanachaiyanont,et al.  The Usefulness of Homeostatic Measurement Assessment-Insulin Resistance (HOMA-IR) for Detection of Glucose Intolerance in Thai Women of Reproductive Age with Polycystic Ovary Syndrome , 2012, International journal of endocrinology.

[21]  S. Bhattacharya,et al.  Effects of ethinyl estradiol and desogestrel on clinical and metabolic parameters in Indian patients with polycystic ovary syndrome , 2012, The journal of obstetrics and gynaecology research.

[22]  G. Ferns,et al.  Selection of the appropriate method for the assessment of insulin resistance , 2011, BMC medical research methodology.

[23]  J. Vieira,et al.  Insulin resistance index (HOMA-IR) in the differentiation of patients with non-alcoholic fatty liver disease and healthy individuals. , 2010, Arquivos de gastroenterologia.

[24]  S. Kahn,et al.  Interactions of sex hormone-binding globulin with target cells , 2010, Molecular and Cellular Endocrinology.

[25]  F. Akın,et al.  SHBG levels correlate with insulin resistance in postmenopausal women. , 2009, European journal of internal medicine.

[26]  I. Stratton,et al.  Preanalytical, Analytical, and Computational Factors Affect Homeostasis Model Assessment Estimates , 2008, Diabetes Care.

[27]  A. Janež,et al.  Assessment of insulin resistance in young women with polycystic ovary syndrome , 2008, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[28]  R. Hoffman Indices of insulin action calculated from fasting glucose and insulin reflect hepatic, not peripheral, insulin sensitivity in African‐American and Caucasian adolescents , 2008, Pediatric diabetes.

[29]  Pedagógia,et al.  Cross Sectional Study , 2019 .

[30]  Irene M Stratton,et al.  Comparison of 11 human insulin assays: implications for clinical investigation and research. , 2007, Clinical chemistry.

[31]  F. Conus,et al.  Characteristics of metabolically obese normal-weight (MONW) subjects. , 2007, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.

[32]  E. Ding,et al.  Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. , 2006, JAMA.

[33]  L. Groop,et al.  Contribution of insulin-stimulated glucose uptake and basal hepatic insulin sensitivity to surrogate measures of insulin sensitivity. , 2004, Diabetes care.

[34]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[35]  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. , 2004, Fertility and sterility.

[36]  A. Astrup,et al.  Obesity : Preventing and managing the global epidemic , 2000 .

[37]  B. Balkau,et al.  Comment on the provisional report from the WHO consultation , 1999, Diabetic medicine : a journal of the British Diabetic Association.

[38]  M. S. Khan,et al.  Androgens, Estrogens, and Second Messengers , 1998, Steroids.